For: | Dong WG, Sun XM, Yu BP, Luo HS, Yu JP. Role of VEGF and CD44v6 in differentiating benign from malignant ascites. World J Gastroenterol 2003; 9(11): 2596-2600 [PMID: 14606105 DOI: 10.3748/wjg.v9.i11.2596] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i11/2596.htm |
Number | Citing Articles |
1 |
Solange Maria Diniz Bizzo, Débora Dummer Meira, José Marinaldo Lima, Jânio da Silva Mororó, José Cláudio Casali‐da‐Rocha, Maria Helena Faria Ornellas. Peritoneal VEGF burden as a predictor of cytoreductive surgery outcome in women with epithelial ovarian cancer. International Journal of Gynecology & Obstetrics 2010; 109(2): 113 doi: 10.1016/j.ijgo.2009.11.021
|
2 |
Konstantinos Karatolios, Sabine Pankuweit, Rainer Georg Moosdorf, Bernhard Maisch. Vascular Endothelial Growth Factor in Malignant and Benign Pericardial Effusion. Clinical Cardiology 2012; 35(6): 377 doi: 10.1002/clc.21967
|
3 |
Amene Saghazadeh, Nima Rezaei, Martin E. Rottenberg. Vascular endothelial growth factor levels in tuberculosis: A systematic review and meta-analysis. PLOS ONE 2022; 17(5): e0268543 doi: 10.1371/journal.pone.0268543
|
4 |
Akihiro Sako, Joji Kitayama, Dai Shida, Rika Suzuki, Teruyuki Sakai, Hideo Ohta, Hirokazu Nagawa. Lysophosphatidic Acid (LPA)-Induced Vascular Endothelial Growth Factor (VEGF) by Mesothelial Cells and Quantification of Host-Derived VEGF in Malignant Ascites. Journal of Surgical Research 2006; 130(1): 94 doi: 10.1016/j.jss.2005.08.007
|
5 |
Solange Maria Diniz Bizzo, Débora Dummer Meira, José Marinaldo Lima, Jânio da Silva Mororó, Fábio Carvalho de Barros Moreira, José Cláudio Casali-da-Rocha, Maria Helena Faria Ornellas. Serum albumin and vascular endothelial growth factor in epithelial ovarian cancer: looking at adnexal tumor drainage. Archives of Gynecology and Obstetrics 2011; 283(4): 855 doi: 10.1007/s00404-010-1491-4
|
6 |
Bogdan Zalewski. Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features. World Journal of Gastroenterology 2004; 10(4): 583-585 doi: 10.3748/wjg.v10.i4.583
|
7 |
Feilim Mac Gabhann, Aleksander S. Popel. Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle. American Journal of Physiology-Heart and Circulatory Physiology 2007; 292(1): H459 doi: 10.1152/ajpheart.00637.2006
|
8 |
Jing Wang, Qin-shu Kang, Xiao-guang Lv, Jia Song, Na Zhan, Wei-guo Dong, Wei-hua Huang, Yuan-Soon Ho. Simple Patterned Nanofiber Scaffolds and Its Enhanced Performance in Immunoassay. PLoS ONE 2013; 8(12): e82888 doi: 10.1371/journal.pone.0082888
|
9 |
Xiaoping Wang, Wei Chen, Xu Li, Huanping Lin, Qiaoxia Wang. Heat shock protein 72 associated with CD44v6 in human colonic adenocarcinoma. Cell Biology International 2008; 32(7): 860 doi: 10.1016/j.cellbi.2008.02.009
|
10 |
Samar Masoumi Moghaddam, Afshin Amini, David L. Morris, Mohammad H. Pourgholami. Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer. Cancer and Metastasis Reviews 2012; 31(1-2): 143 doi: 10.1007/s10555-011-9337-5
|
11 |
Saeed Zarei, Ali Ahmad Bayat, Reza Hadavi, Ahmad R. Mahmoudi, Banafsheh Tavangar, Yasaman Vojgani, Mahmood Jeddi-Tehrani, Zahra Amirghofran. Production and Characterization of a Peptide-based Monoclonal Antibody Against CD44 Variant 6. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 2015; 34(1): 36 doi: 10.1089/mab.2014.0077
|
12 |
Sylvia Stadlmann, Albert Amberger, Juergen Pollheimer, Guenther Gastl, Felix Albert Offner, Raimund Margreiter, Alain Gustave Zeimet. Ovarian carcinoma cells and IL-1β-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions. Gynecologic Oncology 2005; 97(3): 784 doi: 10.1016/j.ygyno.2005.02.017
|
13 |
|
14 |
|
15 |
|
16 |
Sebastian Kobold, Susanna Hegewisch-Becker, Karin Oechsle, Karin Jordan, Carsten Bokemeyer, Djordje Atanackovic. Intraperitoneal VEGF Inhibition Using Bevacizumab: A Potential Approach for the Symptomatic Treatment of Malignant Ascites?. The Oncologist 2009; 14(12): 1242 doi: 10.1634/theoncologist.2009-0109
|
17 |
Hao Jiang, Wei Zhao, Wei Shao. Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis. Tumor Biology 2014; 35(8): 7383 doi: 10.1007/s13277-014-2150-3
|
18 |
Xiaoping Wang, Qiaoxia Wang, Huanping Lin, Sanzhong Li, Lijun Sun, Yixin Yang. HSP72 and gp96 in gastroenterological cancers. Clinica Chimica Acta 2013; 417: 73 doi: 10.1016/j.cca.2012.12.017
|
19 |
Ahmed Abdel-Razik, Nasser Mousa, Hatem Elalfy, Tarek Fouad Sheta, Mahmoud Awad, Mostafa Abdelsalam, Rania Elhelaly, Rasha Elzehery, Nawal S. Gouda, Waleed Eldars. A Novel Combination of C-Reactive Protein and Vascular Endothelial Growth Factor in Differential Diagnosis of Ascites. Journal of Gastrointestinal Cancer 2017; 48(1): 50 doi: 10.1007/s12029-016-9873-x
|
20 |
David Semela, Jean-François Dufour. Signaling Pathways in Liver Diseases. 2005; : 91 doi: 10.1007/3-540-27194-5_8
|
21 |
Na Zhan, Wei-Guo Dong, Jing Wang. The clinical significance of vascular endothelial growth factor in malignant ascites. Tumor Biology 2016; 37(3): 3719 doi: 10.1007/s13277-015-4198-0
|
22 |
Xiaoping Wang, Huanping Lin, Qiaoxia Wang, Jiqing Bai, Xiaoping Ying, Lansheng Guo, Yanhong Zhao, Yan Fang. Interaction between Heat Shock Protein 72 and CD44v6 in Human Colonic adenocarcinoma. 2010 4th International Conference on Bioinformatics and Biomedical Engineering 2010; : 1 doi: 10.1109/ICBBE.2010.5516371
|
23 |
I. NASCIMENTO, R. SCHAER, D. LEMAIRE, S. FREIRE, B. PAULE, S. CARVALHO, R. MEYER, H. SCHAER-BARBOSA. Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nonmalignant ascites. APMIS 2004; 112(9): 585 doi: 10.1111/j.1600-0463.2004.apm1120904.x
|
24 |
Hae Kyung Lee, Hiun Suk Chae, Jin Soo Kim, Hyung Keun Kim, Young Seok Cho, Sang Young Rho, Jin-Hyoung Kang, Seok Goo Cho, Hong Seok Jang, Kyungja Han. Vascular endothelial growth factor levels in ascites between chemonaive and chemotreated patients. Yonsei Medical Journal 2008; 49(3): 429 doi: 10.3349/ymj.2008.49.3.429
|
25 |
Meike Körner, Beatrice Waser, Jean Claude Reubi, Laurence J. Miller. CCK2 receptor splice variant with intron 4 retention in human gastrointestinal and lung tumours. Journal of Cellular and Molecular Medicine 2010; 14(4): 933 doi: 10.1111/j.1582-4934.2009.00859.x
|
26 |
Li Du, Ning Wei, Rakhi Maiwall, Yuhu Song. Differential diagnosis of ascites: etiologies, ascitic fluid analysis, diagnostic algorithm. Clinical Chemistry and Laboratory Medicine (CCLM) 2024; 62(7): 1266 doi: 10.1515/cclm-2023-1112
|
27 |
|
28 |
Katarina Galic Jerman, Borut Kobal, Marina Jakimovska, Ivan Verdenik, Katarina Cerne. Control values of ovarian cancer tumor markers and standardisation of a protocol for sampling peritoneal fluid and performing washing during laparoscopy. World Journal of Surgical Oncology 2014; 12(1) doi: 10.1186/1477-7819-12-278
|
29 |
Dongrong Situ, Hao Long, Peng Lin, Zhihua Zhu, Jiang Wang, Xu Zhang, Zeming Xie, Tiehua Rong. Expression and prognostic relevance of CD44v6 in stage I non-small cell lung carcinoma. Journal of Cancer Research and Clinical Oncology 2010; 136(8): 1213 doi: 10.1007/s00432-010-0771-5
|
30 |
Jacob Kment, Daniel Newsted, Stephanie Young, Michael C. Vermeulen, Brian J. Laight, Peter A. Greer, Yan Lan, Andrew W. Craig. Blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responses. British Journal of Cancer 2024; 130(12): 2003 doi: 10.1038/s41416-024-02677-9
|
31 |
Xiaoping Wang, Huanping Lin, Qiaoxia Wang, Jiqing Bai, Xiaoping Ying. Co-localization of heat shock protein 72 and CD44v6 in human colonic adenocarcinoma. 2010 3rd International Conference on Biomedical Engineering and Informatics 2010; : 2467 doi: 10.1109/BMEI.2010.5639790
|
32 |
David Semela, Jean-François Dufour. Signaling Pathways in Liver Diseases. 2010; : 421 doi: 10.1007/978-3-642-00150-5_28
|